Authors/Disclosures
|
Reza Seyedsadjadi, MD
|
Dr. Seyedsadjadi has received personal compensation for serving as an employee of American Neurological Association. Dr. Seyedsadjadi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SwanBio Therapeutics. Dr. Seyedsadjadi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Seyedsadjadi has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. The institution of Dr. Seyedsadjadi has received research support from Cystinosis Research Foundation. |
|
Michael R. Rose, MD
(Kings College Hospital)
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Shree Pandya, DPT
|
No disclosure on file |
|
Carlayne E. Jackson, MD, FÂ鶹´«Ã½Ó³»
(University of Texas Health Science Center at San Antonio)
|
Dr. Jackson has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for Â鶹´«Ã½Ó³». The institution of Dr. Jackson has received research support from NIH. The institution of Dr. Jackson has received research support from Massachussetts General Hospital. |
|
John T. Kissel, MD, FÂ鶹´«Ã½Ó³»
|
Dr. Kissel has nothing to disclose. |
|
|
No disclosure on file |
|
Syed F. Ali, MD
(University of Arkansas Medical Sciences)
|
No disclosure on file |